Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS

v3.21.2
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Jun. 30, 2021
Dec. 31, 2020
Current assets:    
Cash and cash equivalents $ 65,757 $ 72,211
Accounts receivable, net 265,856 286,314
Inventory, net 134,722 132,341
Other current assets and prepaid expenses 47,627 32,313
Assets held for sale 33,067 0
Total current assets 547,029 523,179
Property, plant and equipment, net 106,652 140,554
Intangible assets, net 445,515 475,002
In-process research and development 590,200 590,200
Goodwill 677,360 680,602
Investments 8,945 15,731
Operating lease right-of-use assets 36,349 37,735
Other assets 9,600 10,060
Total assets 2,421,650 2,473,063
Current liabilities:    
Accounts payable 88,512 100,883
Accrued expenses 187,172 240,869
Current maturities of operating leases 10,102 9,028
Liabilities associated with assets held-for-sale 233 0
Current portion of lines of credit and notes payable 17,961 24,703
Total current liabilities 303,980 375,483
Operating lease liabilities 30,605 29,760
Convertible notes 183,198 221,989
Deferred tax liabilities 136,416 137,208
Other long-term liabilities, principally contract liabilities, contingent consideration and lines of credit 24,866 37,072
Total long-term liabilities 375,085 426,029
Total liabilities 679,065 801,512
Equity:    
Common Stock - $0.01 par value, 1,000,000,000 shares authorized; 689,817,971 and 670,585,576 shares issued at June 30, 2021 and December 31, 2020, respectively 6,898 6,706
Treasury Stock - 8,655,082 and 549,907 shares at June 30, 2021 and December 31, 2020, respectively (1,791) (1,791)
Additional paid-in capital 3,214,351 3,152,694
Accumulated other comprehensive loss (9,932) (4,225)
Accumulated deficit (1,466,941) (1,481,833)
Total shareholders’ equity 1,742,585 1,671,551
Total liabilities and equity $ 2,421,650 $ 2,473,063